Sarepta snags its partner’s CSO, Louise Rodino-Klapac, to lead new gene therapy unit – Endpoints News
Endpoints News |
Sarepta snags its partner’s CSO, Louise Rodino-Klapac, to lead new gene therapy unit
Endpoints News Putting one more arrow in its muscular dystrophy quiver, Sarepta has snagged a top executive from one of its partners to lead the company’s newly-created gene therapy unit. Louise Rodino-Klapac is coming on board as vice president of gene therapy. |
CNBC |
Celgene CEO: We don’t have to be No. 1 to thrive with new cancer therapy to replace chemo
CNBC [are] realizing is that this class of medicine of CAR T therapy — whether its lymphoma, leukaemia or myeloma — will replace existing chemotherapy,” Alles said in a “Squawk Box” interview. CAR T-cell therapy takes a patient’s own immune cells, called … |
Genetic Literacy Project |
As world’s scientists herald CRISPR revolution, will Africa follow?
Genetic Literacy Project I am only wondering if those spreading the misinformation are currently following the recent “super” GMO technique referred to as Clusters of Regularly Interspaced Short Palindromic Repeats (CRISPR), which is being hailed and accepted worldwide. And … |